Psycho-oncology: Where have we been? Where are we going?

被引:41
作者
Dolbeault, S
Szporn, A
Holland, JC
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA
[2] Inst Curie, Psychiat & Oncopsychol Unit, Paris, France
关键词
psycho-oncology; psychosocial oncology; history; psychobiological aspects;
D O I
10.1016/S0959-8049(99)00190-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article reviews the development of the subspeciality of psyche-oncology and its contributions to patient care, encouraging more attention to and research into the care of the total patient: the physical, psychological, social and spiritual aspects of care. The result is enhanced quality of life as the patient is studied in the domains of Living that are important, extending across the continuum of care from diagnosis to palliative care. In addition, cancer prevention and early detection depends largely on changing attitudes and behaviours that put people at greater risk. This is an important area of research for psycho-oncologists. In the past two decades, research has contributed to our understanding of the psychological responses that accompany a cancer diagnosis. Oncologists better recognise psychological distress and psychiatric disorders such as anxiety, depression and delirium (in hospitalised patients) as frequent comorbid disorders. The development of valid assessment tools for the patients' self-report has been important. Increasingly, outcome measures in controlled trials of new therapies include quality of Life, and no longer look at survival alone. The future will continue to bring new challenges to psyche-oncology as patients face new challenges in treatment. A major aim of the next century will be to bring this integrated approach to all patients in an affordable manner. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1554 / 1558
页数:5
相关论文
共 50 条
  • [21] History of pediatric liver transplantation. Where are we coming from? Where do we stand?
    Otte, JB
    [J]. PEDIATRIC TRANSPLANTATION, 2002, 6 (05) : 378 - 387
  • [22] Nonmedical prescribing: where are we now?
    Cope, Louise C.
    Abuzour, Aseel S.
    Tully, Mary P.
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2016, 7 (04) : 165 - 172
  • [23] Aspirin resistance: Where are we now?
    Abaci, Okay
    Kilickesmez, Kadriye Orta
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (04) : 370 - 373
  • [24] Forest management in Central Africa: where are we?
    Nasi, R.
    Cassagne, B.
    Billand, A.
    [J]. INTERNATIONAL FORESTRY REVIEW, 2006, 8 (01) : 14 - 20
  • [25] Hysteroscopy: where did we start, and where are we now? The compelling story of what many considered the "Cinderella" of gynecological endoscopy
    Vitale, Salvatore Giovanni
    Giannini, Andrea
    Carugno, Jose
    van Herendael, Bruno
    Riemma, Gaetano
    Pacheco, Luis Alonso
    Drizi, Amal
    Mereu, Liliana
    Bettocchi, Stefano
    Angioni, Stefano
    Haimovich, Sergio
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (04) : 1877 - 1888
  • [26] Highlighting Contributions of Behavioral and Social Sciences in Advancing Public Health: Where We've Come, Where We're Headed
    Alber, Julia M.
    Green, Lawrence W.
    Gambescia, Stephen F.
    McLeroy, Kenneth R.
    Sofalvi, Alan
    Auld, M. Elaine
    [J]. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2021, 27 (06) : E220 - E227
  • [27] Genetics of Focal Epilepsies: What Do We Know and Where Are We Heading?
    Perucca, Piero
    [J]. EPILEPSY CURRENTS, 2018, 18 (06) : 356 - 362
  • [28] Median Arcuate Ligament Syndrome: Where Are We Today?
    Maddox, Kayden
    Farrell, Timothy M.
    Pascarella, Luigi
    [J]. AMERICAN SURGEON, 2025, 91 (02) : 284 - 291
  • [29] Radiosurgery: Where we were, are, and may be in the third millennium
    Niranjan, A
    Lunsford, LD
    [J]. NEUROSURGERY, 2000, 46 (03) : 531 - 543
  • [30] Integrative oncology: are we doing enough to integrate psycho-education?
    Sagar, Stephen M.
    [J]. FUTURE ONCOLOGY, 2016, 12 (24) : 2779 - 2783